Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nehal Masood

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
JPMA. the Journal of the Pakistan Medical Association|November 13, 2012
Psychosocial impact of cancer on adult patientsYasmin Abdul Rashid, Zahra Abdul Ghafoor, Nehal Masood, et al.
Journal of Cancer|February 18, 2011
Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropeniaAsim Jamal Shaikh, Samira Ahmed Bawany, Nehal Masood, et al.
Journal of the American Academy of Dermatology|June 22, 2002
Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantationNehal Masood, Kenneth J Russell, John E Olerud, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2008
Factors influencing in-hospital length of stay and mortality in cancer patients suffering from febrile neutropeniaAmar Lal, Yasmin Bhurgri, Nida Rizvi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 14, 2008
Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomasAmar Lal, Yasmin Bhurgri, Irfan Vaziri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2020
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 TrialJames Chih-Hsin Yang, D Ross Camidge, Cheng-Ta Yang, et al.
Clinical Colorectal Cancer|October 27, 2016
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC StudyAnn-Lii Cheng, Gerardo Cornelio, Lin Shen, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
JPMA. the Journal of the Pakistan Medical Association|November 13, 2012
Psychosocial impact of cancer on adult patientsYasmin Abdul Rashid, Zahra Abdul Ghafoor, Nehal Masood, et al.
Journal of Cancer|February 18, 2011
Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropeniaAsim Jamal Shaikh, Samira Ahmed Bawany, Nehal Masood, et al.
Journal of the American Academy of Dermatology|June 22, 2002
Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantationNehal Masood, Kenneth J Russell, John E Olerud, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|August 21, 2008
Factors influencing in-hospital length of stay and mortality in cancer patients suffering from febrile neutropeniaAmar Lal, Yasmin Bhurgri, Nida Rizvi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|November 14, 2008
Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomasAmar Lal, Yasmin Bhurgri, Irfan Vaziri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 11, 2020
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 TrialJames Chih-Hsin Yang, D Ross Camidge, Cheng-Ta Yang, et al.
Clinical Colorectal Cancer|October 27, 2016
Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC StudyAnn-Lii Cheng, Gerardo Cornelio, Lin Shen, et al.
Pageof 4